Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Human leukocyte antigen class I-restricted cytotoxic T-lymphocyte Epstein-Barr virus epitopes

From: Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

Human leukocyte antigen Protein Epitope position Epitope sequence
A2 EBNA3A 596 to 604 SVRDRLARL
A2.01 EBNA3C 284 to 293 LLDFVRFMGV
A2.01 LMP2 329 to 337 LLWTLVVLL
A2.01 LMP2 426 to 434 CLGGLLTMV
A2.01 BMLF1 280 to 288 GLCTLVAML
A2.06 LMP2 453 to 461 LTAGFLIFL
A3 EBNA3A 603 to 611 RLRAEAQVK
A11 EBNA3B 399 to 408 AVFDRKSDAK
A11 EBNA3B 416 to 424 IVTDVSVIK
A11 LMP2 340 to 350 SSCSSCPLSKI
A23 LMP2 131 to 139 PYLFWLAAI
A24 EBNA3A 246 to 253 LYSIFFDY
A24 LMP2 419 to 427 TYGPVFMCL
A24.02 EBNA3B 217 to 225 TYSAGIVKI
A25 LMP2 442 to 451 VMSNTLLSAW
A29 EBNA3A 491 to 499 VFSDGRVAC
A30.02 EBNA3A 176 to 184 AYSSWMYSY
B7 EBNA3A 502 to 510 GPAPAGPIV
B7 EBNA3A 379 to 387 RPPIFIRRL
B7 EBNA3C 881 to 889 QPRAPIRPI
B8 EBNA3A 158 to 166 QAKWRLQTL
B8 EBNA3A 325 to 333 FLRGRAYGL
B8 BZLF1 190 to 197 RAKFKQLL
B27.02 EBNA3B 244 to 254 RRARSLSAERY
B27.02/.04/.05 EBNA3C 258 to 266 RRIYDLIEL
B27.04 LMP2 236 to 244 RRRWRRLTV
B27.05 EBNA3B 149 to 157 HRCQAIRKK
B27.05 EBNA3C 249 to 258 LRGKWQRRYR
B27.05 EBNA3C 343 to 351 FRKAQIQGL
B35 EBNA3A 458 to 466 YPLHEQHGM
B35 EBNA3B 488 to 496 AVLLHEESM
B35 BZLF1   EPLPQGQLTAY
B35.01 EBNA1 407 to 417 HPVGEADYFEY
B39 EBNA3C 271 to 278 HHIWQNLL
B44 EBNA3B 567 to 666 VEITPYKPTW
B44.02 EBNA3C 281 to 290 EENLLDFVRF
B44.02 EBNA3C 335 to 343 KEHVIQNAF
B44.03 EBNA3C 163 to 171 EGGVGWRHW
B60 LMP2 200 to 208 IEDPPFNSL
B62 EBNA3A 406 to 414 LEKARGSTY
B62 EBNA3B 831 to 839 GQGGSPTAM
B62 EBNA3C 213 to 222 QNGALAINTF